Arquives

July 2017 Tangen Biosciences receives a Notice of Intent to fund the SBIR/NIH phase I grant application for Rapid Detection of Multiple Sepsis Pathogens.April 2017 Tangen Biosciences holds Pre-Submission meeting with FDA to discuss parameters for the clinical testing...